Concepedia

Luciano Adorini

LA

223

Publications

24K

Citations

78

H-Index

1976

Active since

Affiliations

Roche (Italy)(Current)

Intercept Pharmaceuticals (United States)

University of Florence

Biogen (Italy)

National Agency for New Technologies, Energy and Sustainable Economic Development

Luciano Adorini is an author at Roche (Italy) specializing in medicine, immunology, and autoimmunity.

ORCID

Top concepts

Publications per year

1976–2023

223

Publications

223

1α,25-Dihydroxyvitamin D3 Inhibits Differentiation, Maturation, Activation, and Survival of Dendritic Cells Leading to Impaired Alloreactive T Cell Activation

Giuseppe Penna, Luciano Adorini · The Journal of Immunology · 2000 · 1.2K citations

Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease

Sunder Mudaliar, Robert R. Henry, Arun J. Sanyal et al. · Gastroenterology · 2013 · 906 citations

, , +9

Maturation Stages of Mouse Dendritic Cells in Growth Factor–dependent Long-Term Cultures

Claudia Winzler, Patrizia Rovere, María Rescigno et al. · The Journal of Experimental Medicine · 1997 · 837 citations · Full text

Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease

Raffaella Maria Gadaleta, Karel J. van Erpecum, Bas Oldenburg et al. · Gut · 2011 · 827 citations

Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development

Juliette Mouriès, Paola Brescia, Alessandra Silvestri et al. · Journal of Hepatology · 2019 · 618 citations · Full text

Rows per page

1–5 of 223